Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (25)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Grimm, C.
Right arrow Articles by Graw, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grimm, C.
Right arrow Articles by Graw, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics Pages 697-710  


Isolation and embryonic expression of the novel mouse gene Hic1, the homologue of HIC1, a candidate gene for the Miller-Dieker syndrome
Introduction
Results
   Isolation of the murine Hic1 and its genomic structure
   Deduced amino acid sequence and domain structure
   Chromosomal localization of Hic1
   Expression of the murine Hic1 mRNA
   Hic1 expression in sclerotomal and body wall mesenchymes
   Expression of Hic1 in limb and cranio-facial mesenchymes
   Expression of Hic1 in mesenchymes facing epithelia of inner organs
Discussion
   Genomic organization of murine Hic1
   Chromosomal localization of Hic1
   Comparison of the expressions of Hic1 and [gamma]FBP during development
   Hic1 is expressed in perineural mesenchymes
   Hic1 is activated in embryonic anlagen of tissues that are affected in MDS patients
Materials And Methods
   Animals and embryos
   Expressed sequence tags
   Isolation of the murine Hic1
   Northern analysis
   Chromosomal localization
   In situ hybridization
Acknowledgements
Abbreviations
Note added in proof
References


Isolation and embryonic expression of the novel mouse gene <I>Hic1</I>, the homologue of <I>HIC1</I>, a candidate gene for the Miller-Dieker syndrome

Isolation and embryonic expression of the novel mouse gene Hic1, the homologue of HIC1, a candidate gene for the Miller-Dieker syndrome

Christina Grimm1,+, Ralf Spörle1,2,+, Thomas E. Schmid1, Ilse-Dore Adler1, Jerzy Adamski1, Klaus Schughart1,§ and Jochen Graw1,*

1GSF-National Research Center for Environment and Health, Institute of Mammalian Genetics, D-85764 Neuherberg, Germany and 2Department of Biology, Albert-Ludwigs-University Freiburg, D-79104 Freiburg, Germany

Received November 23, 1998; Revised and Accepted January 28, 1999

DDBJ/EMBL/GenBank accession nos AF036582, AF036334, AF111712

The human gene HIC1 (hypermethylated in cancer) maps to chromosome 17p13.3 and is deleted in the contiguous gene disorder Miller-Dieker syndrome (MDS) [Makos-Wales et al. (1995) Nature Med., 1, 570-577; Chong et al. (1996) Genome Res., 6, 735-741]. We isolated the murine homologue Hic1, encoding a zinc-finger protein with a poxvirus and zinc-finger (POZ) domain and mapped it to mouse chromosome 11 in a region exhibiting conserved synteny to human chromosome 17. Comparison of genomic and cDNA sequences predicts two exons for the murine Hic1. The second exon exhibits 88% identity to the human HIC1 on DNA level. During embryonic development, Hic1 is expressed in mesenchymes of the sclerotomes, lateral body wall, limb and cranio-facial regions embedding the outgrowing peripheral nerves during their differentiation. During fetal development, Hic1 additionally is expressed in mesenchymes apposed to precartilaginous condensations, at many interfaces to budding epithelia of inner organs, and weakly in muscles. We observed activation of Hic1 expression in the embryonic anlagen of many tissues displaying anomalies in MDS patients. Besides lissencephaly, MDS patients exhibit facial dysmorphism and frequently additional birth defects, e.g. anomalies of the heart, kidney, gastrointestinal tract and the limbs (OMIM 247200). Thus, HIC1 activity may correlate with the defective development of the nose, jaws, extremities, gastrointestinal tract and kidney in MDS patients.

INTRODUCTION

HIC1 (hypermethylated in cancer) (1) resides in the Miller-Dieker syndrome (MDS) critical region on human chromosome 17p13.3. HIC1 encodes a C2-H2 zinc-finger protein with a poxvirus and zinc-finger (POZ) domain. The POZ domain, also known as broad complex, tramtrack, bric à brac (BTB) or zinc-finger N-terminal region (ZIN) domain, is a hydrophobic, ~120 amino acid protein-protein interaction motif that is generally found at the N-terminus of either actin binding or DNA binding proteins. All tested POZ-C2-H2 zinc-finger proteins act as transcription factors. Several POZ proteins are localized in specific dots within the nucleus. Some POZ proteins have been implicated in chromatin remodeling (1,2; reviewed in ref. 3). HIC1 is a potential tumor suppressor gene since it is hypermethylated and its expression is downregulated in several common types of cancer (4). Moreover, loss of heterozygosity at the HIC1 locus was observed e.g. in medulloblastoma and lung cancers (5,6 and references therein).

MDS (OMIM 247200) is a severe genetic disorder caused by hemizygous deletion of a critical region in 17p13.3, indicating haploinsufficiency of the involved genes. The syndrome is characterized by lissencephaly type I (smooth brain, agyria, pachygyria), characteristic facial appearence, and occasionally additional birth defects (7-11). Many patients die within the first few years of life (9). Lissencephaly has also been observed without facial dysmorphism, and was referred to as isolated lissencephaly (ILS). The type I lissencephaly observed in ILS and MDS is caused by deletions or mutations of the LIS1/PAFAH1B1 gene (12-15) that codes for the 45 kDa subunit of the platelet activating factor acetylhydrolase (16). The deletions observed in MDS always include LIS1/PAFAH1B1 and other telomeric loci (13,17). At least four genes reside in this region, these are MNT/ROX (encoding the MAX-interactor protein) at D17S379 (18,19), OVCA1/DPH2L and OVCA2 at D17S28/YNH37 (20,21) and HIC1 at D17S5/YNZ22 (4).

   a
   b

Figure 1. Analysis of the murine Hic1 gene. (a) Isolation of the murine Hic1 gene. The relative sizes and locations of the murine Hic1 EST (IMAGE Consortium CloneID 337 300), two Hic1 cDNA clones (7-3-3 and 6-1) and the genomic Hic1 clone (G6-2) are given schematically. The exons are boxed and the intron is drawn as a line. The region encoding the POZ-domain is shaded and the region encoding the five zinc fingers is indicated by ‘zf’. A potential TATA-box, the putative start codon, the stop codon and the poly(A) signal are indicated. For comparison, the human genomic HIC1 clone (accession no. L41919) (4) and a human EST (IMAGE Consortium CloneID 1520744, accession no. AA91086) are included. Human HIC1 was localized ~2-3 kb centromeric to the marker YNZ22 (4). The dashed line represents unknown sequence and is not drawn into scale. In addition, the position of the short human genomic fragment (accession no. M21147) is indicated. This fragment was placed ~1.8 kb centromeric to the marker YNZ22 (33). (b) Northern blot analysis of total RNA from adult lung. The blot was probed with a fragment of Hic1 3[prime]-UTR. The positions of the 18S and 28S rRNA bands are indicated.


Figure 2. Hic1 genomic DNA and deduced amino acid sequence. The deduced amino acid sequence is shown below the nucleotide sequence of the DNA. The POZ domain is underlined and the C-terminal zinc fingers are boxed. The cluster of basic amino acids is double underlined and the GLDLSK motif is drawn in bold. The CAAT and the TATA consensus sequences are boxed. The CAAT consensus was found on the antisense strand. Presumptive recognition sites for known transcription factors in the 5[prime]-UTR are under- or overlined. The first ATG and the predicted stop codon are shown in bold letters and the consensus polyadenylation site is underlined. The intron is indicated by lower case letters. Abbreviation for transcription factors: AP, activating protein; EGR, early growth response; NF[kappa]B, nuclear factor [kappa]B; Oct, octamer-binding protein; RREB, ras responsive element binding protein, SP1, stimulating protein. The genomic Hic1 and the partial 3 kb Hic1 cDNA sequences are deposited in GenBank under accession nos AF036582 and AF036334, respectively.

Here we report the isolation, genomic structure, chromosomal localization and embryonic expression of the mouse Hic1 gene. Parts of the Hic1 expression territories in the embryo overlap with regions that exhibit abnormalities in MDS patients. The evaluation of its embryonic expression and the mapping of Hic1 to mouse chromosome 11 at 48 cM will be of importance for understanding the genetic basis of MDS.

RESULTS

Isolation of the murine Hic1 and its genomic structure

For the human HIC1, a genomic clone (4) and an expressed sequence tag (EST) have been described. Screening of the EST database (dbEST) with the human HIC1 sequence identified its murine homologue. The corresponding EST clone from the IMAGE consortium (CloneID 337300) (22) encompassed 0.6 kb of 3[prime]-untranslated region (3[prime]-UTR) and was used as a probe to screen cDNA libraries (Fig. 1a). Subsequent screening of two different mouse embryonic day 11 post-coitum (p.c.) cDNA libraries led to the isolation of two overlapping cDNA clones altogether spanning 3 kb. In addition, a genomic DNA library was screened using a subfragment of the isolated cDNA as a probe. A 6 kb fragment of a genomic Hic1 clone including 5[prime]- and 3[prime]-flanking regions was subcloned and sequenced.

Comparison of the genomic Hic1 and the cDNA sequences revealed two exons, separated by a 1451 nt intron (Fig. 1a). The exon-intron boundaries AG/gtgggt . . . cag/G are in good agreement with the splice site consensus sequence (reviewed in ref. 23). The isolated cDNAs encompassed the second exon (2977 nt) and 48 nt of the presumptive first exon. Attempts to isolate further 5[prime] cDNA sequence were unsuccessful. Therefore, the 5[prime] extension of the first exon was predicted by combined northern blot (Fig. 1b) and sequence analysis of the genomic DNA clone. Genomic Hic1 revealed an in-frame ATG within a Kozak consensus initiation sequence (reviewed in ref. 24) 514 nt upstream of the splice donor site of the presumptive first intron. Using the binding site prediction program MatInspector V2.2 (25), a TATA- and a CAAT-box consensus sequence were identified upstream of the putative translation start site (Fig. 2).

Transcription is predicted to start at an adenine, surrounded by pyrimidines, 35 nt downstream of the TATA box (26), resulting in a predicted transcript of 3642 nt: a first exon of 665 nt and a second exon of 2977 nt. Northern analysis of total RNA from lung of adult mice revealed a single transcript of ~3.7 kb (Fig. 1b) suggesting that we identified the complete transcribed region of Hic1 including the entire coding region. Both exons together predicted an open reading frame of 2676 nt, followed by 811 nt of 3[prime]-untranslated sequence. Twenty-four nucleotides upstream of the poly(A) tail, a consensus polyadenylation signal is present (27) (Fig. 2).

Deduced amino acid sequence and domain structure

The deduced Hic1 protein consists of 892 amino acids including a POZ domain and five C2-H2 zinc fingers at the C terminus (Fig. 3). The N-terminal 172 residues exhibit no significant homology to any known protein and are rich in positively charged amino acids, containing a high percentage of Arg (13%) as well as Pro (13%) and Gly (12%). Following the POZ domain, Hic1 contains a cluster of basic amino acids, KKRLKRHGK (Fig. 2). The stretch between the POZ domain and the zinc-finger region (amino acids 334-543) is rich in Pro (20%), Gly (14%) and Ala (10%). Moreover, database searches with the murine Hic1 protein sequence revealed similarities to the chicken [gamma]F-crystallin binding protein ([gamma]FBP) and to the deduced protein of a zebrafish EST (ICRFp524N033) that was sequenced and named hzp1 (hypermethylated in cancer, zinc-finger, POZ-domain) (Fig. 3). Similarly to Hic1 and HIC1, [gamma]FBP encodes also a protein with a POZ domain and five zinc fingers. The deduced protein of the zebrafish hzp1 contains a POZ domain and only four zinc fingers corresponding to the first, third, fourth and fifth zinc fingers of either murine Hic1, human HIC1 or [gamma]FBP (Fig. 3b). Interestingly, a short motif, GLDLSK (Fig. 2), residing in the stretch between the POZ and the zinc-finger domain was identical among murine Hic1, chicken [gamma]FBP and zebrafish hzp1.

   a
   b

Figure 3. Comparison of murine Hic1 to related proteins. (a) Alignment of the deduced amino acid sequence from the human HIC1, the murine Hic1 and the related chicken [gamma]FBP. The POZ domain and the zinc fingers are underlined. Identical amino acids are shaded in gray and similar amino acids are boxed. GenBank accession nos: human HIC1, L41919; [gamma]FBP-B, X79050. (b) Domain structure. Schematic representation of the predicted murine Hic1, human HIC1, chicken [gamma]FBP and the partial zebrafish hzp1 proteins. The percentages indicate amino acid identity of the domains as compared with murine Hic1. The DNA sequence of the zebrafish hzp1 is deposited in GenBank under accession no. AA111712.

Chromosomal localization of Hic1

By fluorescence in situ hybridization (FISH) analysis, using the 16 kb genomic Hic1 clone G6-2 as a probe and a mouse chromosome 11 paint probe, Hic1 was localized to chromosome 11 (Fig. 4). Further genetic mapping was achieved by an interspecific backcross mapping. A sequence length polymorphism in a PCR fragment of the 3[prime]-UTR of Hic1 between C57BL/6J and Mus spretus (Fig. 2) was used to genetically map Hic1 on the C57BL/6J×M.spretus European Collaborative Interspecific Backcross (EUCIB; 28). A total of 130 animals was typed which allowed us to map Hic1 on chromosome 11, 2.3 ± 1.3 cM distal to the anchor locus D11Mit36 with a lod score of 32. Recombination events between Hic1 and interanchor microsatellite markers located Hic1 between D11Mit36 and D11Mit119 (Fig. 5a). The map position at 48 cM on the EUCIB (Fig. 5b) was calculated from the Mbx database (28).


Figure 4. FISH on a methaphase spread with a chromosome 11 paint probe (green) and the genomic Hic1 probe (red). Chromosomes were counterstained with DAPI and banded with actinomycin D.


Figure 5. Genetic mapping of the mouse Hic1 employing the EUCIB. (a) Genotype analysis. Animals were typed for Hic1 (this study) and the markers D11Mit10, D11Mit36, D11Mit31, D11Nds19 and D11Mit119 (28). Each column represents the genotype that was identified in the backcross progeny. Open boxes represent homozygous loci (C57BL/6J or M.spretus); filled boxes represent heterozygous loci; n.d., not determined. The number of progeny inheriting each genotype is entered below the column. (b) Partial EUCIB map of mouse chromosome 11. Primary anchor loci D11Mit10, D11Mit36, D11Nds19 and the secondary anchor locus D11Mit31 were typed in all backcross mice; Hic1 was analyzed in 130 animals and the microsatellite markers D11Mit38, D11Mit39, D11Mit119, D11Mit211 and D11Mit325 as well as the genes Cryba1, Cacna1g and Nfe2l1 were typed in different subsets of backcross mice. Map positions in cM of the centromere are given on the left and were calculated with the Mbx database (28). Human orthologues and their chromosomal localizations are given on the right.

Expression of the murine Hic1 mRNA

The spatio-temporal expression of the murine Hic1 gene during embryonic and fetal development was investigated by in situ hybridizations (ISHs) of whole mount embryos and on paraffin sections. As templates for riboprobes, the 0.6 kb EST (IMAGE Consortium CloneID 337300) (Figs 6-8, except Fig. 6c and c[prime]) and the 2.3 kb cDNA clone 7-3-3 (Fig. 6c and c[prime]) were used. No obvious differences were observed in the expression patterns detected by riboprobes generated from both templates. ISHs with the 0.6 kb sense probe from the above EST clone did not yield any signal (data not shown). No expression was observed in the earliest stages investigated, Theiler stages (TS)12-14 (days 8-9 p.c.). At later stages, Hic1 expression was detected in restricted territories of somite derivatives, limb anlagen and cranio-facial mesenchymes (Fig. 6a). Later, Hic1 expression was additionally observed in mesenchymes of the body wall and inner organs (Fig. 6b).


Figure 6. Whole mount in situ hybridizations detecting Hic1 expression in somite derivatives and body wall of mouse embryos at TS17-20. Digoxigenin-labelled Hic1 antisense riboprobes detected expression in somite derivatives (a and b, So) that were localized to spatially separated epaxial and hypaxial mesenchymes, firstly, of the sclerotomes (a, c, d, e and g, arrowheads and ST), and later, also of the lateral body wall (d-h, lM). Epaxial and hypaxial Hic1 expressions in these territories are sharply delineated against the non-expressing mesenchyme of the intercalated, central somite derivatives (g and h, stippled lines mark central territory). Hic1 is also expressed in the limb anlagen (a, b, e, f, g and h), in cranio-facial regions (a and b, arrows, and f), and in mesenchymes associated with spinal ganglia (d, f and h, black arrows) and with skeletal condensations (f and h, VA). (a, b, c, f, g and h) Lateral views; (d and e) dorso-lateral views; (e[prime]) ventral view; (c[prime] and d[prime]) transverse cuts from TS17 and TS19 whole mount embryos, respectively. The horizontal lines connect specific aspects of the Hic1 expression pattern in lateral views of whole embryos (c and d) and transverse cuts (c[prime] and d[prime]). Rostral is to the left (except in c). The white arrows mark bright blue precipitate in the medial mesenchymes typically arising in the depth of whole embryos (d[prime] and h). AT, atlas; c, central; cer, cervical; DM, dermomyotome; e, epaxial; FL, fore limb bud; HL, hind limb bud; G, gut; h, hypaxial; mM, medial mesenchyme; lM, lateral mesenchyme; P, pancreas; SB, somitic bud; SG, spinal ganglion; So, somite derivatives; ST, sclerotome; tho, thoracic; TS, Theiler stage; VA, vertebral arch anlage.

Hic1 expression in sclerotomal and body wall mesenchymes

The mesenchymal sclerotomes and epithelial dermomyotomes arise from the mesodermal segments, the somites. The sclerotomes differentiate into axial skeleton and perineural mesenchymes embedding the spinal cord and trunk peripheral nerves. The dermomyotomes give rise to part of the dermis and the myotomes, progenitors of skeletal muscles (reviewed in ref. 29). Hic1 expression in somite derivatives was first restricted to stripes along their segmental borders spreading in a rostro-caudal direction (Fig. 6a and c, arrowheads) starting in the occipito-cervical region of TS15 (day 9.5 p.c.) embryos (data not shown). Transverse cuts of whole embryos hybridized at TS17 (day 10.5 p.c.) revealed that Hic1 expression was localized to mesenchymes medially to (underlying) the epithelial dermomyotomes and myotomes (Fig. 6c[prime]) that are considered to be sclerotome derivatives (30,31). Interestingly, Hic1 expression was restricted to the dorsal-most (epaxial) edges and ventral (hypaxial) aspects of the mesenchymes underlying the dermomyotomes (Fig. 6c[prime], eST and hST). This spatial restriction of Hic1 expression was retained at later embryonic stages. Medially to (underlying) the dermomyotome derivatives, Hic1 was expressed in separated epaxial and hypaxial mesenchymes at TS17-18 (day 10.75 p.c.; Fig. 6e and g, eST and hST) and TS19 (day 11.5 p.c.; Figs 6d[prime] and 7a, mM). Epaxially, Hic1 was also expressed in the mesenchyme between and dorsally to the spinal ganglia where the dorsal roots enter the spinal cord (Fig. 6d, f and h, black arrows).


Figure 7. ISHs detecting Hic1 expression in mesenchymes surrounding peripheral nerves and limb anlagen at TS19-23. At TS19, Hic1 is expressed in epaxial and hypaxial mesenchymes directly adjacent to the still epithelial somite derivatives (including embryonic muscle anlagen) and the condensing skeletal anlagen (including rib anlagen) (a and b). Moreover, Hic1 is expressed in mesenchymes facing epithelia of inner organs [gut in (a); urogenital ridge in (b)]. At TS22, Hic1 expression is associated with epaxial and hypaxial muscles (d). Hic1 is expressed in mesenchymes surrounding the earliest condensations of the skeletal anlagen of the limb anlagen (e-h). Later, Hic1 expression is also localized to distinct rostral and caudal limb mesenchymes (f and g, arrows). In all stages, Hic1 expression is detected in mesenchymes which embed the elongating peripheral nerves (a-e, and h). Paraffin sections were cut transversally (a, d, e, e[prime] and h), sagittally (b) and horizontally (c). (e[prime]) HE-staining of a section adjacent to that shown in (e). Section planes of (f[prime]) and (h) are shown in (f) and (g), respectively. (f and g) Whole mount fetuses. e, epaxial; G, gut; GR, urogenital ridge; h, hypaxial; HL, hind limb bud; l, lateral; LP, limb plexus; m, medial; M, mesenchyme; PN, peripheral nerve; R, rib anlage; SC, skeletal condensation; SG, spinal ganglion; TS, Theiler stage. Scale bar, 200 µm.


Figure 8. ISHs detecting Hic1 expression in cranio-facial mesenchymes and inner organs at TS19-22. Whole mount embryos (a, b, d and d[prime]) and paraffin sections (c, e, f, g and h) hybridized to Hic1 and, for comparison, to Col2a1 (b) and Myod1 (d[prime]). Hic1 expression in cranio-facial mesenchymes (a, c and d) is mutually exclusive to that of Col2a1 (b), and abuts or partly overlaps the muscle marker Myod1 (d[prime]). Hic1 expressing mesenchymes surround cranial peripheral nerves (a, c and e) and abut epithelial buddings, for example, of the nose (a, c and f), salivary glands (g) and caudal pharyngeal pouches [thymus in (e)]. Hic1 is also expressed in the mesenchymes of a varity of inner organs, e.g. adrenal gland and metanephric kidney (h). During early cornea development, Hic1 is transiently expressed in a ring-shaped mesenchyme (d, arrow). Section plane of (e) is shown in (a). AG, adrenal gland anlage; CN, peripheral cranial nerve; EM, external eye muscles; IE, inner ear; JM, jaw muscle; KT, kidney tubule; Md, mandibular arch; Mx, maxillar arch; No, nose; PN, peripheral nerve; Sal, salivary gland; Th, thymus anlage; Tri, trigeminus ganglion; TS, Theiler stage. Scale bar, 200µm.

During maturation of somite derivatives, Hic1, in addition to its expression in epaxial and hypaxial sclerotome moieties, is activated in mesenchymes laterally to (overlying) the dermomyotomes spreading in a rostro-caudal direction (Fig. 6e, elM and hlM). Finally, continuous bands of Hic1 expression form at the levels of the epaxial and hypaxial somite derivatives (Fig. 6h, elM and hlM). Taken together, from TS17-18 onwards, the epaxial and hypaxial dermomyotome derivatives are surrounded medially and laterally by mesenchymes expressing Hic1 (Figs 6e and e[prime], and 7a and b). Also during fetal development, Hic1 expression is retained in distinct epaxial and hypaxial mesenchymal territories associated with the muscles (Fig. 7d and h, eM and hM). Moreover, Hic1 expressing mesenchymes embed the developing peripheral nerves (Fig. 7a-d) suggesting a role for Hic1 in the specification of perineural mesenchymes from earliest stages of PNS development onwards. Furthermore, during maturation of the body wall, Hic1 expression transiently outlined precartilaginous condensations of vertebral arches and ribs (Figs 6f and h, and 7b).

It is worth noting that the Hic1-expressing mesenchymes associated with the epaxial and hypaxial somite derivatives are sharply delineated against a non-expressing territory overlying the intercalated, central somite derivatives (Fig. 6g and h; stippled lines delineate central somite territories). These borders in the expression of Hic1 appeared to persist until TS21-22 (days 12.5-13.5 p.c.) of fetal development: the epaxial and hypaxial branches of the peripheral nerves are embedded by mesenchymes expressing Hic1, whereas the spinal nerves and most proximal branches of the peripheral nerves are surrounded by non-expressing mesenchymes (Fig. 7d and h).

Expression of Hic1 in limb and cranio-facial mesenchymes

At TS17-18, Hic1 expression started in limb bud mesenchymes near the dorsal and ventral surfaces (Fig. 6a, e and g). Later, Hic1 expression in the limbs diversified into many smaller territories (Fig. 6b, f and h). At TS19, Myod1-expressing muscle anlagen were partly apposed to Hic1-expressing territories (data not shown). ISHs on transverse sections of TS19-22 fetuses revealed Hic1 expression in mesenchymes that outlined the precartilaginous condensations of limb skeletal elements and separated them (Fig. 7e, f[prime] and h). At TS21, Hic1, in addition, was strongly up-regulated along the rostral and caudal edges of the limb stump (Fig. 7g, arrows). Later, strongest expression was found distally, in the digits (Fig. 7f, arrows). Moreover, peripheral nerves also in the limb anlagen were embedded in mesenchymes that expressed high levels of Hic1 (Fig. 7c, e and h).

In cranio-facial mesenchymes, expression of Hic1 was detected near the joint anlage of the jaw [Figs 6a and b, and 8a (short arrow)] and in the nose region [Figs 6a and b, and 8a (long arrow)]. At TS19, Hic1 was also expressed in mesenchymes connecting the trigeminal ganglion with the angle of the jaw and the eye (Figs 6b, and 8a and d). Moreover, mesenchymes in the caudal branchial arches and around the peripheral cranial nerves expressed Hic1 (Fig. 8a, c, d and e). At TS19, Hic1 and Col2a1 were expressed in mutually exclusive territories (Fig. 8a and b) as in the limb buds. Myod1 expression in the anlagen of eye and jaw muscles shared interfaces and partly overlapped with adjacent Hic1 expression territories (Fig. 8d and d[prime]). ISHs on sections of TS19-22 embryos revealed that Hic1 expression in the nose, branchial furrows, branchial pouches (including thymus anlage) and the salivary glands, was localized to mesenchymes adjacent to budding epithelia (Fig. 8c, e, f and g). Finally, mesenchymes associated with many muscle anlagen in branchial to cervical regions expressed weaker levels of Hic1 at TS21/22 (data not shown).

Expression of Hic1 in mesenchymes facing epithelia of inner organs

From early fetal development onwards, Hic1 expression was detected in restricted moieties of pancreas, gut, adrenal gland, kidney anlagen and urogential ridge (Figs 6b and h, 7a and b, and 8h). ISHs on sections of TS19-22 fetuses, in addition, identified expression of Hic1 in restricted mesenchymal territories of esophagus, trachea, lung, diaphragm and stomach. In young anlagen of inner organs, mesenchymal Hic1 expression was found next to epithelia, whereas in more mature anlagen it was also localized more cortically (data not shown). Taken together, many Hic1-expressing mesenchymes were facing epithelial buddings within inner organ anlagen, as well as the still epithelial extremities of the elongating epaxial and hypaxial somite derivatives.

DISCUSSION

The novel murine Hic1 gene was isolated and characterized. Sequence analysis of the murine Hic1 gene revealed that it represents the murine orthologue of the previously described human HIC1 (4). Furthermore, Hic1 is closely related to the chicken [gamma]FBP (32) and the zebrafish hzp1 that was sequenced in this study. Hic1 is activated in embryonic anlagen of some tissues affected in MDS patients. The embryonic expression of Hic1 is in line with a phenotypic contribution of HIC1 to MDS.

Genomic organization of murine Hic1

The comparison of the isolated mouse cDNA clones with the genomic sequence revealed that the murine Hic1 gene contains two exons, separated by a 1.5 kb intron. For the human HIC1 gene only a genomic clone was described and the exon-intron structure was predicted to have three exons (4). The presumptive first human 5[prime]-untranslated exon is not contained in the isolated murine cDNA and in a human HIC1 EST (Fig. 1a). The human second and third exon and the intron (500 bp) in between correspond to the second murine exon. The coding region of the second murine Hic1 exon exhibits 88% identity on DNA level to the corresponding region of the human HIC1 gene. Moreover, the murine Hic1 and human HIC1 nucleotide sequences exhibit 74% identity in the 3[prime]-UTR and 79% identity in ~650 bp of the 3[prime] region of the mouse intron directly upstream of the second murine exon. Interestingly, the exon-intron boundary of the first murine exon exhibited 96% (56 of 58 nt) identity to a human genomic fragment (accession no. M21147; ref. 33) (Fig. 1a). This genomic fragment is contained in a human HIC1 EST (Fig. 1a). It is thus conceivable that also the human HIC1 contains an additional exon in the 5[prime]-region. The reported genomic structure of human HIC1 (4) might represent an alternative transcript.

Chromosomal localization of Hic1

In this study Hic1 was mapped to mouse chromosome 11 at 48 cM employing the EUCIB. Its human orthologue was placed at 17p13.3 (4). Other genes that have been localized on the EUCIB, are Cryba1 at 45 cM, Cacna1g at 60 cM and Nfe2l1 at 61 cM. However, the human orthologues of these three genes map to 17q (Fig. 4b). Thus, Hic1 seems to be localized in a region that exhibits homology to a linkage group on human chromosme 17q. The order of loci that were placed on the Mouse Genome Database (MGD) map support this view (http://www.informatics.jax.org/map.html ). This suggests that chromosomal rearrangements in this region have occured between man and mouse. Similar discontinuities in the gene order within regions of conserved synteny were found among mouse chromosome 16 and the human DiGeorge syndrome region on 22q11.2 (34) and among human chromosome 5 and mouse chromosome 11 (35).

Sequences from the human MDS chromosomal region hybridized to mouse chromosome 11 (36). In addition, the gene order and relative distance of genes localized inside (LIS1/PAFAH1B1, MNT/ROX) and outside (14-3-3e/YWHAE) the MDS critical chromosomal region are conserved between man and mouse. The three genes reside within 1 Mb (37) and have been placed at 44 cM on the mouse chromosome 11 in the MGD map. In human, HIC1 is localized between MNT/ROX and 14-3-3e/YWHAE. For the establishment of an MDS mouse model it would be extremely important to determine the precise localization of Hic1 in relation to these genes.

Comparison of the expressions of Hic1 and [gamma]FBP during development

The POZ domain and the zinc-finger region of the murine Hic1, the human HIC1 and the chicken [gamma]FBP proteins are highly identical, thus suggesting that these proteins might exert similar functions. HIC1 is expressed in all adult tissues analysed (4), but its embryonic expression pattern is not known. Comparison of the murine Hic1 expression and that of a related gene in chicken embryos, [gamma]FBP, revealed some similarities, but also some differences. [gamma]FBP and Hic1 might share expression territories in the sclerotomes, head mesenchyme, developing extremities, pharynx, esophagus, tongue, urogenital ridge, intestine, vertebral arch and rib associated mesenchymes (32 and this study). Despite the absence of detailed information on the [gamma]FBP expression, these general similarities raise the possibility of common functions of these structurally related genes in differentiation of restricted mesenchymes. Moreover, [gamma]FBP was expressed during lens differentiation and functionally implicated in the regulation of the [gamma]F-Crystallin (Crygf) gene (32). However, we did not detect any expression of the murine Hic1 gene in lenses at embryonic, fetal, postnatal (p1, p7, p14, p21), and adult stages by means of ISHs of whole embryos and on paraffin sections (Fig. 8d, and data not shown). Thus, it is not likely that the murine Hic1 gene is implicated in lens differentiation.

Hic1 is expressed in perineural mesenchymes

Embryonic expression of Hic1 was detected in subterritories of the sclerotomes, first intersomitically, and shortly later, in the rostral sclerotome halves. Formation of the segmental array of the components of the peripheral nervous system (PNS), the peripheral ganglia, peripheral nerves and their branches, depends on the permissive properties of the rostral sclerotome halves and the repulsive properties of the caudal sclerotome halves (38-41). Fetal expression of the Hic1 gene was observed in the mesenchymes embedding elongating peripheral nerves in the head, trunk and limbs. Moreover, the spatio-temporal dynamics of Hic1 expression appeared to reflect the course of branching in the peripheral nerves whose target regions are situated more and more peripherally (42,43). Thus, Hic1 expression might play a role in the specification of the sclerotome- and lateral plate-derived as well as cranial mesenchymes implicated in the spatial organization of the PNS. Finally, Hic1 was expressed in mesenchymes at many sites where peripheral nerves probably make contact with the developing muscles and the visceral organs. Interestingly, also the Drosophila POZ-C2-H2 zinc-finger protein lola (longitudinals lacking) plays essential roles in PNS development; lola is required for axon growth and guidance of the intersegmental nerves (44). Moreover, the Drosophila POZ-C2-H2 zinc-finger BR-C (broad complex) regulates muscle attachment in Drosophila (45). The possible contribution of the HIC1 gene to the development of peripheral nerves remains to be elaborated, because also the LIS1/PAFAH1B1 and the MNT/ROX genes may be implicated in peripheral nerve development (12,46). Moreover, in syndromes encompassing lissencephaly, it is difficult to decide if the primary reasons of functional deficiencies of the PNS reside solely in the brain or also the PNS itself.

Hic1 is activated in embryonic anlagen of tissues that are affected in MDS patients

Besides lissencephaly, MDS patients exhibit facial dysmorphism and frequently additional birth defects, e.g. anomalies of the heart, kidney, gastrointestinal tract and the limbs (7-11). Genes deleted in MDS patients are from the centromere to the telomere: LIS1/PAFAH1B1, MNT/ROX, HIC1, OVCA1/DPH2L and OVCA2. In the ILS, mutations and deletions of the LIS1/PAFAH1B1 gene were observed (12-14), and in several cases, also the locus D17S379 residing in the 3[prime]-UTR of the MNT/ROX gene is deleted (10,13). However, the deletions in MDS patients always extend more distally than those in the deleted ILS patients (13). ILS patients sometimes exhibit subtle cranio-facial anomalies reminiscent of those in MDS patients, like bi-temporal hollowing and small jaw, but they rarely have other consistent anomalies (10), strongly suggesting that loss of function in the LIS1/PAFAH1B1 and MNT/ROX genes does not cause the defects in cranio-facial and limb development in MDS patients.

This raises the possibility that other candidate genes in the MDS critical region may be implicated in the defects other than lissencephaly. OVCA1/DPH2L and OVCA2 contain no known functional motifs and are ubiquitously expressed in adult tissues (21) and their developmental expression is not known. In this study, we present the mouse gene Hic1, the orthologue of HIC1, and the striking correlation of its expression with additional sites of defective development in MDS patients.

First, MDS patients exhibit a characteristic facial appearence consisting of a prominent forehead, small jaw (micrognathia), bi-temporal hollowing, short nose with upturned nares, a broad nasal bridge and a protuberant upper lip. Frequently, wrinkling of the forehead was also observed (9). During development, Hic1 is expressed in the first branchial arch that gives rise to the maxillar and mandibular components of the jaw and the lips. In addition, Hic1 expression was observed in the mesenchyme surrounding the infolding nasal epithelium in embryonic and fetal development. Thus, the developmental expression of Hic1 in spatially restricted cranio-facial mesenchymes whose derivatives are affected in MDS patients suggests that HIC1 may be implicated in the morphogenesis of the nose, jaw and lips.

Secondly, frequently, clinodactyly and sometimes syndactyly were observed in MDS patients (9). Hic1 is expressed in restricted domains of the limb mesenchyme, surrounding the skeletal condensations, as well as in rostral and caudal mesenchymes of each digit anlagen. Thus, loss of HIC1 function may be involved in the limb anomalies observed in MDS.

Thirdly, less frequently, inguinal hernia/omphalocoele was associated with MDS, leading to the suggestion that a gene involved in the closure of the lateral folds or in the return of the midgut from the body stalk to the abdomen during weeks 5-11 of gestation resides at 17p13.3 (11). Hic1 is expressed in the lateral body wall and in the gut. This raises the possibility that its human homologue might play a role in the omphalocoely observed in MDS patients. Finally, two patients with kidney defects were reported and one case with a duodenal atresia (7,8). Hic1 is expressed during development of the gut and the kidney.

In conclusion, the mouse homologue of HIC1, during embryonic development, is expressed in restricted territories of facial mesenchymes (in the branchial arches, surrounding the infolding nasal epithelium and the facial nerves), in the lateral body wall, kidney, gut and limb anlagen. All these expression territories correspond to sites where developmental defects are observed in MDS patients. Therefore, alterations in the gene dosage of the putative transcription factor HIC1 might be involved in the anomalies observed in MDS patients, that are hemizygous for HIC1. An example for gene dosage effects of transcription factors is the Pax family of paired domain proteins. All analyzed heterozygous Pax null mutants exhibit severe developmental defects due to haploinsuffiency (reviewed in ref. 47).

The generation and investigation of heterozygous and homozygous Hic1 knock-out mutant mice will help to reveal if the gene dosage of Hic1 is critical for development and if its human orthologue might be involved in the MDS.

MATERIALS AND METHODS

Animals and embryos

Mice were obtained from the GSF animal facilities. C3H/El and (102/El × C3H/El)F1 hybrid mice were used for the supply of all tissues and the preparation of embryos; for the latter also C57BL/6 mice were used. Staging of embryos was performed according to Kaufman (48). Individual somites and early vertebral condensations were identified according to Spörle and Schughart (49).

Expressed sequence tags

The murine EST of the IMAGE Consortium [CloneID 337300, partial sequence under accession no. W20732; (22)] was obtained from the Human Genome Mapping Project-Resource Centre (HGMP-RC, Cambridge, UK).

The zebrafish EST (ICRFp524N033, partial sequence under accession nos AA497316 and AA497240) was kindly provided by Dr M. Clark (Resource Centre of the German Human Genome Project at the Max-Planck-Institute for Molecular Genetics, Berlin, Germany).

Isolation of the murine Hic1

The 0.6 kb EcoRI-NotI insert of the IMAGE Consortium CloneID 337300 was labelled with [[alpha]-32P]dCTP (Amersham, Braunschweig, Germany) by random priming using the Megaprime DNA labelling system (Amersham) to screen a mouse embryonic day 11 cDNA library of the mouse strain SwissWebster (Novagen, Madison, WI) using stringent hybridization conditions (50% formamide, 5× SSC, 5× Denhardt’s, 0.1% SDS, 100 µg/ml herring sperm DNA, 42°C). Filters (Qiabrane Nylon; Qiagen, Hilden, Germany) were washed in 0.1× SSC/0.1% SDS at 50°C. Sixteen positive clones were isolated and subcloned into pSHlox-1 by in vivo excision. Both strands of the largest clone (7-3-3, 2.3 kb) were sequenced. To obtain the 5[prime] region, a second mouse embryonic day 11 cDNA library of the mouse strain SwissWebster (kindly provided by Dr G. Borsani, TIGEM, Milano, Italy) was screened using a 935 bp fragment (EcoRI-NdeI) of the 5[prime] end of clone 7-3-3 as a probe. One of the isolated clones (6-1), revealing a 1.9 kb insert, exhibited further 5[prime]-coding region of Hic1 and was subcloned into the EcoRI sites of pBluescript KS and sequenced (Sequiserve, Vaterstetten, Germany).

A genomic Hic1 clone was isolated by screening a genomic [lambda]DASH DNA library of the mouse strain 129/SV (50) using the 935 bp EcoRI-NdeI fragment of the 5[prime] region of clone 7-3-3 as a probe. One positive clone (G6-2), containing an ~16 kb insert, was further analyzed. An ~6 kb BamHI fragment of this clone was subcloned into pBluescript KS and sequenced.

Sequence analyses were performed with Gene works 2.45N, clustalW 1.7, MatInspector V2.2 (25) (http://www.gsf.de/biodv/ ) and the ‘BLAST’ network service (51).

Northern analysis

Total RNA from frozen tissues was isolated with RNeasy (Qiagen). Twenty micrograms of total RNA were separated on a 1% agarose gel according to Sambrook et al. (52), transferred onto nylon membranes (Qiabrane Nylon Plus; Qiagen) and UV crosslinked (Stratalinker; Stratagene, Heidelberg, Germany). The 0.6 kb EcoRI-NotI insert of the IMAGE Consortium CloneID 337300 was labelled with [[alpha]-32P]dCTP (Amersham). Labelling and hybridization was performed as described above. Filters were exposed to X-ray film (Kodak XAR; Eastman Kodak Company, New York, NY) at -80°C with two intensifying screens for 3 days.

Chromosomal localization

FISH was performed on metaphase chromosome preparations obtained from mouse bone marrow cells according to standard procedures. The ~16 kb genomic Hic1 clone G6-2 in [lambda]DASH was labelled with biotin-dUTP using the Bio-Prime DNA Labelling System (Gibco BRL, Eggenstein, Germany). The specific chromosome 11 paint probe was obtained from Appligene Oncor; (Heidelberg, Germany). Hybridizations were performed according to Pinkel et al. (53). Metaphase chromosomes were analyzed under an Axiophot microscope (Zeiss, Germany), and pictures were taken by digitizing the microscopic image with the computer program ISIS3 (Metasystems, Altlußheim, Germany) and adapted in Adobe Photoshop 3.0.

Genomic DNA samples from the EUCIB were obtained from the HGMP-RC (28). A polymorphism between M.spretus and C57BL/6J was detected in the 3[prime]-UTR of Hic1 using the primer pair 5[prime]-aaccctgcctctccctgtggc-3[prime]/5[prime]-gtagggctgggagcgtcc-3[prime]. To confine the amplified products, the PCR fragments of M.spretus and C57BL/6J were cloned into the pCR[trade]2.1 vector (Invitrogen, Leek, The Netherlands) and sequenced. A 99 bp fragment was amplified from C57BL/6J and a 95 bp fragment from M.spretus. PCR was run in a GeneAmp PCR System 9600 (Perkin Elmer, Weiterstadt, Germany) using the following conditions: 6 min 94°C, 30 cycles of 94, 60 and 72°C each step lasted for 30 s and a final extension step for 10 min at 72°C. For each PCR reaction, 20 ng genomic DNA, 2 U Taq polymerase (Gibco BRL) 1× Taq reaction buffer (Boehringer Mannheim, Germany), 200 µM of each dNTP (Boehringer Mannheim), 1.5 mM MgCl2, 0.25 µM of each oligonucleotide in a total volume of 20 µl were used. Bands were separated on an 8% polyacrylamide/1× TBE gel. A total of 130 backcross animals were typed for the Hic1 locus. Genetic linkage to EUCIB anchor loci was analysed using the Mbx program (28).

In situ hybridization

RNA probes labelled with Digoxigenin-rUTP (Boehringer Mannheim) were synthesized from linearized cDNA templates according to the manufacturer’s instructions. The IMAGE Consortium CloneID 337300 was linearized with EcoRI and NotI, and synthesized with T3 and T7 RNA polymerases for antisense and sense probes, respectively. The clone 7-3-3 was linearized with SacI and transcribed with SP6 RNA polymerase for the antisense probe. The Myod1 and the Col2a1 probes were previously described (54,55).

ISHs of whole mount embryos (WISHs) were performed according to Wilkinson (56) and Rosen and Beddington (57) with modifications described by Spörle and Schughart (58). WISH embryos were cut transversely with a scalpel, and section planes were documented. Staining of WISH embryos by precipitating BM Purple AP Substrate (Boehringer Mannheim) with some riboprobes yielded two different colours in the same reaction. In WISHs, bright blue instead of purple precipitates were observed in the expression territories of Hic1 that were situated medially to the hypaxial somitic buds (Fig. 6d[prime] and h, white arrows).

ISHs on paraffin sections were performed as previously described (59,60) with the following modifications. After fixation, embryos were dehydrated in isopropanol, transferred to Histowax saturated with isopropanol and embedded in Histowax (Cambridge Instruments, Nußloch, Germany). Slides were fixed for 30 min at room temperature in both 4% PFA/PBS prehybridization fixation steps, and treated for 3 min with 2 µg/ml proteinase K in 1 mM EDTA, 20 mM Tris-HCl (pH 7.0). Before hybridization, the slides were washed twice for 2 min in 2× SSC, and incubated for at least 30 min in 0.1 M Tris, 0.1 M glycine. Hybridization solution (60 µl/slide) contained 50% formamide, 5× SSC, 5% dextran sulfate, 2 mg/ml heparin, 100 µg/ml tRNA, 0.1% Tween-20 (pH adjusted with citric acid to 6.0) and a 1:100 or 1:50 dilution of the riboprobes. Riboprobes were the same as for WISH. Hybridization occurred overnight at 65°C under a siliconized coverslip or a parafilm strip. Following hybridization, slides were washed for 1-2 h in 0.5× SSC, 20% formamide at 65°C. Sections were treated with 10 µg/ml RNaseA for 30 min at 37°C in NTE (0.5 M NaCl, 5 mM EDTA, 10 mM Tris-HCl, pH 7.0-7.5), then washed for 4 h in 0.5× SSC, 20% formamide at 65°C and for 30 min in 2× SSC, and blocked for 1 h at room temperature in 1% blocking reagent (Boehringer Mannheim)in MAB-T (0.1 M maleic acid, 0.15 M NaCl, 0.1% Tween-20,pH 7.5). A 1:5000 dilution of anti-digoxigenin-AP conjugate (Boehringer Mannheim) was preincubated for at least 1 h in 1% blocking reagent in MAB-T at 4°C. Slides were incubated with the antibody overnight at 4°C, washed for 6 h in TBS-T, for 30 min in NTM-T (0.1 M NaCl, 50 mM MgCl2, 0.1 M Tris-HCl, pH 9.5, 0.1% Tween-20), and stained using centrifuged BM purple AP substrate (Boehringer Mannheim) in 0.3% Tween-20 for 1-7 days at 4°C and/or room temperature. Slides were washed in NTM-T, then in distilled water, and embedded in KAISER’S glycerol gelatin (Merck, Darmstadt, Germany). Sections were analysed under a Zeiss Axioplan microscope and documented with a high resolution CCD colour camera (Fujix HC-2000; Fuji) connected to an Apple PowerMacintosh. Pictures were adjusted for brightness, contrast and colour balance in Adobe Photoshop3.0.

ACKNOWLEDGEMENTS

The authors thank Drs J. Favor, K. Imai and T. Immervoll as well as N. Klopp for helpful discussions. Oligonucleotides were synthesized at the BIODV unit at the GSF by Utz Linzner. The Col2a1 probe was kindly provided by Dr K.S. Cheah (Department of Biochemistry, University of Hong Kong, China) and the Myod1 probe was obtained from Dr R.L. Davis (Department of Genetics, Hutchinson Cancer Research Center, Seattle, Washington, DC). An aliquot from an E11-mouse cDNA library was kindly provided by Dr G. Borsani (TIGEM, Milano, Italy). The genomic [lambda]DASH DNA library of the mouse strain 129/SV was a gift of Dr A.G. Reaume (Cephalon Inc., West Chester, PA). The zebrafish EST ICRFp524N033 was obtained from Dr M. Clark (Resource Centre of the German Human Genome Project at the Max-Planck-Institute for Molecular Genetics, Berlin, Germany).

ABBREVIATIONS

BTB, broad complex, tramtrack, bric à brac; EST, expressed sequence tag; EUCIB, European Collaborative Interspecific Backcross; [gamma]FBP, [gamma]F-crystallin binding protein; HIC1, hypermetylated in cancer 1; hzp1, hypermethylated in cancer, zinc-finger, POZ-domain 1; ILS, isolated lissencephaly sequence; LIS1/PAFAH1B1, lissencephaly 1/platelet activating factor acetyl hydrolase 45 kDa subunit; MDS, Miller-Dieker syndrome; MGD, Mouse Genome Database; MNT/ROX, MAX-interactor protein; p.c., post coitum; POZ, poxvirus and zinc finger; TS, Theiler stage; ZIN, zinc-finger N-terminal domain.

NOTE ADDED IN PROOF

After submission of the revised manuscript, the corrected sequence of the human HIC1 gene and its genomic structure was published (GenBank accession no. L41919). The correct human HIC1 sequence and its deduced protein sequence support the results obtained for the murine Hic1 reported here.

REFERENCES

1. David, G., Alland, L., Hong, S.H., Wong, C.W., DePinho, R.A. and Dejean, A. (1998) Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene, 16, 2549-2556. MEDLINE Abstract

2. Dhordain, P., Albagli, O., Lin, R.J., Ansieau, S., Quief, S., Leutz, A., Kerckaert, J.P., Evans, R.M. and Leprince, D. (1997) Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc. Natl Acad. Sci. USA, 94, 10762-10767. MEDLINE Abstract

3. Albagli, O., Dhordain, P., Deweindt, C., Lecocq, G. and Leprince, D. (1995) The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins. Cell Growth Differ., 6, 1193-1198. MEDLINE Abstract

4. Makos-Wales, M., Biel, M.A., el Deiry, W., Nelkin, B.D., Issa, J.P., Cavenee, W.K., Kuerbitz, S.J. and Baylin, S.B. (1995) p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nature Med., 1, 570-577. MEDLINE Abstract

5. Steichen-Gersdorf, E., Baumgartner, N., Kreczy, A., Maier, H., Fink, F.M. (1997) Deletion mapping on chromosome 17p in medulloblastoma. Br. J. Cancer, 76, 1284-1287. MEDLINE Abstract

6. Konishi, H., Takahashi, T., Kozaki, K., Yatabe, Y., Mitsudomi, T., Fujii, Y., Sugiura, T., Matsuda, H., Takahashi, T. and Takahashi, T. (1998) Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers. Oncogene, 17, 2095-2100. MEDLINE Abstract

7. Miller, J.Q. (1963) Lissencephaly in 2 siblings. Neurology, 13, 841-850.

8. Dieker, H., Edwards, R.H., ZuRhein, G., Chou, S.M., Hartman, H.A. and Opitz, J.M. (1969) The lissencephaly syndrome. Birth Defects, 5, 53-64.

9. Dobyns, W.B., Curry, C.J., Hoyme, H.E., Turlington, L. and Ledbetter, D.H. (1991) Clinical and molecular diagnosis of Miller-Dieker syndrome. Am. J. Hum. Genet., 48, 584-594. MEDLINE Abstract

10. Dobyns, W.B., Reiner, O., Carrozzo, R. and Ledbetter, D.H. (1993) Lissencephaly. A human brain malformation associated with deletion of the LIS1 gene located at chromosome 17p13. J. Am. Med. Assoc., 270, 2838-2842.

11. Chitayat, D., Toi, A., Babul, R., Blaser, S., Moola, S., Yarkoni, D., Sermer, M., Johnson, J.A., Vasjar, J. and Teshima, I. (1997) Omphalocele in Miller-Dieker syndrome: expanding the phenotype. Am. J. Med. Genet., 69, 293-298. MEDLINE Abstract

12. Reiner, O., Carrozzo, R., Shen, Y., Wehnert, M., Faustinella, F., Dobyns, W.B., Caskey, C.T. and Ledbetter, D.H. (1993) Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats. Nature, 364, 717-721. MEDLINE Abstract

13. Chong, S.S., Pack, S.D., Roschke, A.V., Tanigami, A., Carrozzo, R., Smith, A.C., Dobyns, W.B. and Ledbetter, D.H. (1997) A revision of the lissencephaly and Miller-Dieker syndrome critical regions in chromosome 17p13.3. Hum. Mol. Genet., 6, 147-155. MEDLINE Abstract

14. Lo Nigro, C., Chong, C.S., Smith, A.C., Dobyns, W.B., Carrozzo, R. and Ledbetter, D.H. (1997) Point mutations and an intragenic deletion in LIS1, the lissencephaly causative gene in isolated lissencephaly sequence and Miller-Dieker syndrome. Hum. Mol. Genet., 6, 157-164. MEDLINE Abstract

15. Hirotsune, S., Fleck, M.W., Gambello, M.J., Bix, G.J., Chen, A., Clark, G.D., Ledbetter, D.H., McBain, C.J. and Wynshaw-Boris, A. (1998) Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nature Genet., 19, 333-339. MEDLINE Abstract

16. Hattori, M., Adachi, H., Tsujimoto, M., Arai, H. and Inoue, K. (1994) Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase. Nature, 370, 216-218. MEDLINE Abstract

17. Chong, S.S., Tanigami, A., Roschke, A.V. and Ledbetter, D.H. (1996) 14-3-3eta has no homology to Lis1 and lies telomeric to it on Chromosome 17p13.3 outside the Miller-Dieker syndrome chromosome region. Genome Res., 6, 735-741. MEDLINE Abstract

18. Carrozzo, R. and Ledbetter, D.H. (1993) Dinucleotide repeat polymorphism mapping to the critical region for lissencephaly (17p13.3). Hum. Mol. Genet., 2, 615. MEDLINE Abstract

19. Meroni, G., Reymond, A., Alcalay, M., Borsani, G., Tanigami, A., Tonlorenzi, R., Nigro, C.L., Messali, S., Zollo, M., Ledbetter, D.H., Brent, R., Ballabio, A. and Carrozzo, R. (1997) Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor. EMBO J., 16, 2892-2906. MEDLINE Abstract

20. Phillips, N.J., Zeigler, M.R. and Deaven, L.L. (1996) A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3. Cancer Lett., 102, 85-90. MEDLINE Abstract

21. Schultz, D.C., Vanderveer, L., Berman, D.B., Hamilton, T.C., Wong, A.J. and Godwin, A.K. (1996) Identification of two candidate tumor suppressor genes on chromosome 17p13.3. Cancer Res., 56, 1997-2002. MEDLINE Abstract

22. Lennon, G., Auffray, C., Polymeropoulos, M. and Soares, M.B. (1996) The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics, 33, 151-152. MEDLINE Abstract

23. Padgett, R.A., Grabowski, P.J., Konarska, M.M., Seiler, S. and Sharp, P.A. (1986) Splicing of messenger RNA precursors. Annu. Rev. Biochem., 55, 1119-1150. MEDLINE Abstract

24. Kozak, M. (1996) Interpreting cDNA sequences: some insights from studies on translation. Mamm. Genome, 7, 563-574. MEDLINE Abstract

25. Quandt, K., Frech, K., Karas, H., Wingender, E. and Werner, T. (1995) MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res., 23, 4878-4884. MEDLINE Abstract

26. Smale, S.T. and Baltimore, D. (1989) The `initiator' as a transcription control element Cell, 57, 103-113. MEDLINE Abstract

27. Fitzgerald, M. and Shenk, T. (1981) The sequence 5[prime]-AAUAAA-3[prime] forms parts of the recognition site for polyadenylation of late SV40 mRNAs. Cell, 24, 251-260. MEDLINE Abstract

28. Breen, M., Deakin, L., Macdonald, B., Miller, S., Sibson, R., Tarttelin, E., Avner, P., Bourgade, F., Guenet, J.-L., Montagutelli, X., Poirier, C., Simon, D., Tailor, D., Bishop, M., Kelly, M., Rysavy, F., Rastan, S., Norris, D., Shepherd, D., Abbott, C., Pilz, A., Hodge, S., Jackson, I., Boyd, Y., Blair, H., Maslen, G., Todd, J.A., Reed, P.W., Stoye, J., Ashworth, A., McCarthy, L., Cox, R., Schalkwyk, L., Lehrach, H., Klose, J., Gangadharan, U. and Brown, S. (1994) Towards high resolution maps of the mouse and human genomes-a facility for ordering markers to 0.1 cM resolution. European Backcross Collaborative Group. Hum. Mol. Genet., 3, 621-627. MEDLINE Abstract

29. Gossler, A. and Hrabé de Angelis, M. (1998) Somitogenesis. Curr. Top. Dev. Biol., 38, 225-287.

30. Blechschmidt, E. (1961) The Stages of Human Development before Birth. Karger, Basel, Switzerland.

31. Verbout, A.J. (1985) The development of the vertebral column. Adv. Anat. Embryol. Cell Biol., 89, 143-149.

32. Liu, Q., Shalaby, F., Puri, M.C., Tang, S. and Breitman, M.L. (1994) Novel zinc finger proteins that interact with the mouse gamma F-crystallin promoter and are expressed in the sclerotome during early somitogenesis. Dev. Biol., 165, 165-177. MEDLINE Abstract

33. Wolff, R.K., Nakamura, Y. and White, R. (1988) Molecular characterization of a spontaneously generated new allele at a VNTR locus: no exchange of flanking DNA sequence. Genomics, 3, 347-351. MEDLINE Abstract

34. Botta, A., Lindsay, E.A., Juresic, V. and Baldini, A. (1997) Comparative mapping of the DiGeorge syndrome region in mouse shows inconsistent gene order and different degree of gene conservation. Mamm. Genome, 8, 890-895. MEDLINE Abstract

35. Watkins-Chow, D.E., Buckwalter, M.S., Newhouse, M.M., Lossie, A.C., Brinkmeier, M.L. and Camper, S.A. (1997) Genetic mapping of 21 genes on mouse chromosome 11 reveals disruptions in linkage conservation with human chromosome 5. Genomics, 40, 114-122. MEDLINE Abstract

36. Ledbetter, D.H., Ledbetter, S.A., vanTuinen, P., Summers, K.M., Robinson, T.J., Nakamura, Y., Wolff, R., White, R., Barker, D.F., Wallace, M.R. et al.) (1989) Molecular dissection of a contiguous gene syndrome: frequent submicroscopic deletions, evolutionarily conserved sequences and a hypomethylated `island' in the Miller-Dieker chromosome region. Proc. Natl Acad. Sci. USA, 86, 5136-5140. MEDLINE Abstract

37. Hirotsune, S., Pack, S.D., Chong, S.S., Robbins, C.M., Pavan, W.J., Ledbetter, D.H. and Wynshaw-Boris, A. (1997) Genomic organization of the murine Miller-Dieker/lissencephaly region: conservation of linkage with the human region. Genome Res., 7, 625-634. MEDLINE Abstract

38. Teillet, M., Kalcheim, C. and LeDouarin, N. (1987) Formation of the dorsal root ganglia in the avian embryo: segmental origin and migratory behavior of neural crest progenitor cells. Dev. Biol., 120, 329-347. MEDLINE Abstract

39. Kalcheim, C. and Teillet, M.-A. (1989) Consequences of somite manipulation on the development of dorsal root ganglia. Development, 106, 85-93. MEDLINE Abstract

40. Stern, C.D., Jaques, K.F., Lim, T.M., Fraser, S.E. and Keynes, R.J. (1991) Segmental lineage restrictions in the chick embryo spinal cord depend on the adjacent somites. Development, 113, 239-244. MEDLINE Abstract

41. Krull, C., Lansford, R., Gale, N., Collazo, A., Marcelle, C., Yancopoulos, G., Fraser, S. and Bronner-Fraser, M. (1997) Interactions of Eph-related receptors and ligands confer rostrocaudal pattern to trunk neural crest migration. Curr. Biol., 7, 571-580. MEDLINE Abstract

42. Goodrich, E.S. (1930) Studies on the Structure and Development of Vertebrates. 1st edn. Macmillan and Co., London.

43. Kardong, K.V. (1998). Vertebrates: Comparative Anatomy, Function, Evolution. 2nd edn. WCB/McGraw-Hill, Boston, MA.

44. Giniger, E., Tietje, K., Jan, L.Y. and Jan, Y.N. (1994) lola encodes a putative transcription factor required for axon growth and guidance in Drosophila. Development, 120, 1385-1398. MEDLINE Abstract

45. Sandstrom, D.J., Bayer, C.A., Fristrom, J.W. and Restifo, L.L. (1997) Broad-complex transcription factors regulate thoracic muscle attachment in Drosophila. Dev. Biol., 181, 168-185. MEDLINE Abstract

46. Hurlin, P.J., Queva, C. and Eisenman, R.N. (1997) Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev., 11, 44-58. MEDLINE Abstract

47. Dahl, E., Koseki, H. and Balling, R. (1997) Pax genes and organogenesis. Bioessays, 19, 755-765. MEDLINE Abstract

48. Kaufman, M.H. (1992) The Atlas of Mouse Development. Academic Press, London.

49. Spörle, R. and Schughart, K. (1997) System to identify individual somites and their derivatives in the developing mouse embryo. Dev. Dyn., 210, 216-226. MEDLINE Abstract

50. Reaume, A.G., de Sousa, P.A., Kulkarni, S., Langille, B.L., Zhu, D., Davies, T.C., Juneja, S.C., Kidder, G.M. and Rossant, J. (1995) Cardiac malformation in neonatal mice lacking connexin43. Science, 267, 1831-1834. MEDLINE Abstract

51. Altschul, S.F., Madden, T.L., Schaffer, A.A., Zhang, J., Zhang, Z., Miller, W. and Lipman, D.J. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res., 25, 3389-3402. MEDLINE Abstract

52. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, NY.

53. Pinkel, D., Landegent, J., Collins, C., Fuscoe, J., Segraves, R., Lucas, J. and Gray, J. (1988) Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc. Natl Acad. Sci. USA, 85, 9138-9142. MEDLINE Abstract

54. Davis, R., Weintraub, H. and Lassar, A.B. (1987) Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell, 51, 987-1000. MEDLINE Abstract

55. Cheah, K.S., Lau, E.T., Au, P.K. and Tam, P.P. (1991) Expression of the mouse alpha 1 (II) collagen gene is not restricted to cartilage during development. Development, 111, 945-953. MEDLINE Abstract

56. Wilkinson, D.G. (1992) In Wilkinson, D.G. (ed.), In Situ Hybridization-A Practical Approach. IRL Press, Oxford, UK, pp. 75-83.

57. Rosen, B. and Beddington, R.S.P. (1993) Whole mount in situ hybridization in the mouse embryo: gene expression in three dimensions. Trends Genet., 9, 162-167. MEDLINE Abstract

58. Spörle, R. and Schughart, K. (1998) Paradox segmentation along inter- and intrasomitic borderlines is followed by dysmorphology of the axial skleleton in the open brain (opb) mouse mutant. Dev. Genet., 22, 359-373. MEDLINE Abstract

59. Jostarndt, K., Puntschart, A., Hoppeler, H. and Billeter, R. (1994) The use of 33P-labelled riboprobes for in situ hybridizations: localization of myosin alkali light-chain mRNAs in adult human skeletal muscle. Histochem. J., 26, 32-40. MEDLINE Abstract

60. Neubüser, A., Koseki, H. and Balling, R. (1995) Characterization and developmental expression of Pax9, a paired-box-containing gene related to Pax1. Dev. Biol., 170, 701-716. MEDLINE Abstract


*To whom correspondence should be addressed. Tel: +49 89 3187 2610; Fax: +49 89 3187 2210; Email: graw@gsf.de
§Present address: TRANSGENE S.A., 11 rue de Molsheim, F-67082 Strasbourg, France
+These authors contributed equally to this work


This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals
Comments and feedback: www-admin{at}oup.co.uk
Last modification: 10 Mar 1999
Copyright©Oxford University Press, 1999.

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
K. Ganguly, M. Depner, C. Fattman, K. Bein, T. D. Oury, S. C. Wesselkamper, M. T. Borchers, M. Schreiber, F. Gao, E. von Mutius, et al.
Superoxide dismutase 3, extracellular (SOD3) variants and lung function
Physiol Genomics, May 13, 2009; 37(3): 260 - 267.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. M. Comi, P. Mehta, L. A. Hatfield, and M. M. Dowling
Sturge-Weber Syndrome Associated With Other Abnormalities: A Medical Record and Literature Review
Arch Neurol, December 1, 2005; 62(12): 1924 - 1927.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Pinte, N. Stankovic-Valentin, S. Deltour, B. R. Rood, C. Guerardel, and D. Leprince
The Tumor Suppressor Gene HIC1 (Hypermethylated in Cancer 1) Is a Sequence-specific Transcriptional Repressor: DEFINITION OF ITS CONSENSUS BINDING SEQUENCE AND ANALYSIS OF ITS DNA BINDING AND REPRESSIVE PROPERTIES
J. Biol. Chem., September 10, 2004; 279(37): 38313 - 38324.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Deltour, S. Pinte, C. Guerardel, B. Wasylyk, and D. Leprince
The Human Candidate Tumor Suppressor Gene HIC1 Recruits CtBP through a Degenerate GLDLSKK Motif
Mol. Cell. Biol., July 1, 2002; 22(13): 4890 - 4901.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Lengler, E. Krausz, S. Tomarev, A. Prescott, R. A. Quinlan, and J. Graw
Antagonistic action of Six3 and Prox1 at the {{gamma}}-crystallin promoter
Nucleic Acids Res., January 15, 2001; 29(2): 515 - 526.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. G. Carter, M. A. Johns, X. Zeng, L. Zhou, M. C. Zink, J. L. Mankowski, D. M. Donovan, and S. B. Baylin
Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome
Hum. Mol. Genet., February 12, 2000; 9(3): 413 - 419.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Deltour, C. Guerardel, and D. Leprince
Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: The case of HIC-1 and gamma FBP-B
PNAS, December 21, 1999; 96(26): 14831 - 14836.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. E. Hoatlin, Y. Zhi, H. Ball, K. Silvey, A. Melnick, S. Stone, S. Arai, N. Hawe, G. Owen, A. Zelent, et al.
A Novel BTB/POZ Transcriptional Repressor Protein Interacts With the Fanconi Anemia Group C Protein and PLZF
Blood, December 1, 1999; 94(11): 3737 - 3747.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Guerardel, S. Deltour, S. Pinte, D. Monte, A. Begue, A. K. Godwin, and D. Leprince
Identification in the Human Candidate Tumor Suppressor Gene HIC-1 of a New Major Alternative TATA-less Promoter Positively Regulated by p53
J. Biol. Chem., January 26, 2001; 276(5): 3078 - 3089.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (25)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Grimm, C.
Right arrow Articles by Graw, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grimm, C.
Right arrow Articles by Graw, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?